NCT06471504 Use of Eye Tracking to Aid in Autism Risk Detection
| NCT ID | NCT06471504 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Indiana University |
| Condition | Autism |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-01-08 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-01-08 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures.
Eligibility Criteria
Inclusion Criteria: * Young children ages 12-48 months scheduled for health care visits at Riley Hospital for Children at Indiana University Health clinics (e.g., Pediatric Care Center clinics). * Children must have English- or Spanish-speaking caregivers. * Children must have a legal guardian that is able to provide consent. Exclusion Criteria: * Child is younger than 12 months or older than 48 months. * Child's caregiver(s) is not English- or Spanish-speaking.
Contact & Investigator
Rebecca R McNally Keehn, PhD, HSPP
PRINCIPAL INVESTIGATOR
IU School of Medicine
Frequently Asked Questions
Who can join the NCT06471504 clinical trial?
This trial is open to participants of all sexes, aged 12 Months or older, up to 48 Months, studying Autism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06471504 currently recruiting?
Yes, NCT06471504 is actively recruiting participants. Contact the research team at mcnallyr@iu.edu for enrollment information.
Where is the NCT06471504 trial being conducted?
This trial is being conducted at Indianapolis, United States.
Who is sponsoring the NCT06471504 clinical trial?
NCT06471504 is sponsored by Indiana University. The principal investigator is Rebecca R McNally Keehn, PhD, HSPP at IU School of Medicine. The trial plans to enroll 100 participants.